Sherratt E J, Thomas A W, Gagg J W, Alcolado J C
University of Wales College of Medicine, UK.
Biotechniques. 1996 Mar;20(3):430-2. doi: 10.2144/19962003430.
Mitochondrial DNA (mtDNA) mutations have been implicated in an increasing number of human diseases. Many of these mutations are heteroplasmic and are only present at low levels in readily accessible human tissue such as blood. The technique of single-stranded conformational polymorphism (SSCP) allows the detection of mtDNA variants from peripheral blood, but characterization of these variants by automated sequencing is hampered by the low level of heteroplasmy. We have therefore developed a technique for the enrichment of mtDNA mutations that allows reliable sequence data to be obtained even if the variant mtDNA represents only 1% of the total mtDNA. The procedure involves the excision, purification and subsequent PCR amplification of selected DNA fragments from SSCP gels. The techniques can be applied to other heterogeneous mutations such as mosaic mutations in skin biopsies or somatic oncogene mutations in tumor tissue.
线粒体DNA(mtDNA)突变与越来越多的人类疾病有关。这些突变中的许多是异质性的,并且仅以低水平存在于易于获取的人体组织(如血液)中。单链构象多态性(SSCP)技术可以从外周血中检测mtDNA变异体,但由于异质性水平较低,通过自动测序对这些变异体进行表征受到阻碍。因此,我们开发了一种富集mtDNA突变的技术,即使变异的mtDNA仅占总mtDNA的1%,也能获得可靠的序列数据。该过程包括从SSCP凝胶中切除、纯化选定的DNA片段,然后进行PCR扩增。该技术可应用于其他异质性突变,如皮肤活检中的镶嵌突变或肿瘤组织中的体细胞癌基因突变。